DoMore Diagnostics Gets CE-IVD Mark for Its Histotype Px Colorectal Algorithm

DoMore Diagnostics has received a CE-IVD mark for its Histotype Px Colorectal cancer screening software that predicts patient outcomes based on an analysis of digital histology images.

The artificial intelligence-based software includes a deep-learning algorithm that was “trained” using almost 100 million images, building on research by the Institute for Cancer Genetics and Informatics at Oslo University Hospital.

This is the first CE-marked product to utilize artifice

The software analyzes high-resolution scans from standard stained slides, providing much shorter turnaround times than is possible using existing methods.

Histotype Px Colorectal is “the first CE-marked product to use artificial intelligence to predict patient outcome based on advanced image analysis,” the Oslo, Norway-based company said.